FierceBiotech Feb 3, 2026 Pfizer's $10B monthly GLP-1 bet generates competitive weight loss in phase 2b
Illumina Feb 3, 2026 Illumina Partners with San Diego Zoo for Genomic Sequencing of Endangered Species - Intellectia AI
Illumina Feb 3, 2026 Illumina and the San Diego Zoo Wildlife Alliance partner to sequence the Frozen Zoo®, supporting critical conservation genetics efforts globally - PR Newswire
PLoS Biology Feb 3, 2026 Resource landscape shapes the composition and stability of the human vaginal microbiota
Agilent Feb 3, 2026 Agilent to Announce First-Quarter Fiscal Year 2026 Financial Results on Feb. 25 - BioSpace
Endpoints News Feb 3, 2026 Ultragenyx unwraps data that may be central to its gene therapy resubmission
Agilent Feb 3, 2026 Agilent Technologies : and Virscidian Announce Collaboration to Streamline Access to OpenLab CDS Data in Analytical Studio - marketscreener.com
Endpoints News Feb 3, 2026 Pfizer takes $4.4B charge related to cancer drug in fourth-quarter earnings
Endpoints News Feb 3, 2026 Pfizer’s Metsera-originated monthly GLP-1 cuts weight by 10.5% at six months
Lonza News Feb 3, 2026 45% earnings growth over 1 year has not materialized into gains for Lonza Group (VTX:LONN) shareholders over that period - Yahoo Finance